Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
1,409 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00978523 | Study of AR-12 (2-Amino-N-[4-[5-(2 Phenanthrenyl)-3-(Trifluoromethyl)-1H-pyrazol-1-yl] Phenyl]-Acetamide) in Adult Patients With Advanced or Recurrent Solid Tumors or Lymphoma | completed | Phase 1 | 35 | Arno TherapeuticsINDUSTRY | 2 | Jan 29, 2014 | clinicaltrials |
| NCT00727831 | Methotrexate, Glucarpidase, and Leucovorin in Treating Patients With Newly Diagnosed Primary Central Nervous System Lymphoma | completed | Phase 1 / Phase 2 | 4 | University College, LondonOTHER | 1 | Jan 27, 2014 |
| clinicaltrials |
| NCT00515866 | Study to Assess the Safety & Tolerability of a PARP Inhibitor in Combination With Gemcitabine in Pancreatic Cancer | completed | Phase 1 | 68 | AstraZenecaINDUSTRY | 2 | Dec 20, 2013 | clinicaltrials |
| NCT00003697 | Dimethylxanthenone Acetic Acid in Treating Patients With Solid Tumors | completed | Phase 1 | 3 | University of GlasgowOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00003698 | Chemotherapy in Treating Patients With Solid Tumors | completed | Phase 1 | 35 | University of GlasgowOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00004076 | PNU 166148 in Treating Patients With Metastatic Solid Tumors | unknown | Phase 1 | 30 | University of GlasgowOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00474760 | Study Of Anti-IGF-IR CP-751,871 In Patients With Solid Tumors | completed | Phase 1 | 65 | PfizerINDUSTRY | 2 | Dec 17, 2013 | clinicaltrials |
| NCT01523353 | Prehabilitation in Liver Surgery | completed | Phase 1 | 37 | Liverpool University Hospitals NHS Foundation TrustOTHER_GOV | 1 | Dec 17, 2013 | clinicaltrials |
| NCT01527929 | Pharmacokinetics and Safety Study of Cabazitaxel in Cancer Patients With Renal Impairment | completed | Phase 1 | 25 | SanofiINDUSTRY | 5 | Dec 4, 2013 | clinicaltrials |
| NCT01714765 | Dose Escalation Study Investigating Everolimus and Dovitinib in Metastatic Clear Cell Renal Cancer(DEVELOP) | completed | Phase 1 | 17 | Queen Mary University of LondonOTHER | 1 | Nov 13, 2013 | clinicaltrials |
| NCT01653158 | CP-751,871 In Combination With Docetaxel In Advance Non-hematologic Malignancies | completed | Phase 1 | 46 | PfizerINDUSTRY | 1 | Oct 30, 2013 | clinicaltrials |
| NCT01233492 | Boron Phenylalanine With or Without Mannitol in Treating Patients With Glioblastoma Multiforme | terminated | Phase 1 | 36 | Cancer Research UKOTHER | 1 | Oct 8, 2013 | clinicaltrials |
| NCT01258816 | The Pharmacokinetics and Cardiac Properties of Elacytarabine (CP-4055) | completed | Phase 1 | 43 | Clavis PharmaINDUSTRY | 2 | Sep 23, 2013 | clinicaltrials |
| NCT01948362 | Sulforadex in Healthy Volunteers SAD | completed | Phase 1 | 29 | Evgen PharmaINDUSTRY | 1 | Sep 23, 2013 | clinicaltrials |
| NCT00003747 | Carboplatin and Temozolomide in Treating Patients With Unresectable or Metastatic Melanoma | unknown | Phase 1 | 30 | Mount Vernon Cancer Centre at Mount Vernon HospitalOTHER | 1 | Sep 20, 2013 | clinicaltrials |
| NCT00007826 | Monoclonal Antibody Therapy and/or Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer | unknown | Phase 1 / Phase 2 | — | OnyvaxINDUSTRY | 1 | Sep 20, 2013 | clinicaltrials |
| NCT00031902 | Rituximab Plus Combination Chemotherapy in Treating Patients With HIV-Related Non-Hodgkin's Lymphoma | unknown | Phase 1 | — | Lymphoma Trials OfficeOTHER | 1 | Sep 20, 2013 | clinicaltrials |
| NCT00032149 | Combination Chemotherapy Plus Filgrastim in Treating Patients With HIV-Related Non-Hodgkin's Lymphoma | unknown | Phase 1 / Phase 2 | 30 | Lymphoma Trials OfficeOTHER | 1 | Sep 20, 2013 | clinicaltrials |
| NCT00360854 | Erlotinib Alone or in Combination With Radiation Therapy in Treating Young Patients With Refractory or Relapsed Malignant Brain Tumors or Newly Diagnosed Brain Stem Glioma | unknown | Phase 1 | 48 | Children's Cancer and Leukaemia GroupOTHER | 2 | Sep 20, 2013 | clinicaltrials |
| NCT00405743 | A Phase I/II Study of CP-4055 in Patients With Refractory/Relapsed Hematologic Malignancies | completed | Phase 1 / Phase 2 | 153 | Clavis PharmaINDUSTRY | 6 | Sep 18, 2013 | clinicaltrials |
| NCT00956436 | Sorafenib With BIIB022 in Hepatocellular Carcinoma (HCC) | completed | Phase 1 | 40 | BiogenINDUSTRY | 4 | Sep 16, 2013 | clinicaltrials |
| NCT00562068 | Alemtuzumab and Combination Chemotherapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IV Peripheral T-Cell Lymphoma | unknown | Phase 1 | 30 | Cancer Research UKOTHER | 1 | Aug 26, 2013 | clinicaltrials |
| NCT00829205 | Se-Methyl-Seleno-L-Cysteine, Rituximab, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Diffuse Large B-Cell Lymphoma That Has Relapsed or Not Responded to Treatment | withdrawn | Phase 1 / Phase 2 | 0 | Cancer Research UKOTHER | 1 | Aug 26, 2013 | clinicaltrials |
| NCT00946543 | Intensity-Modulated Radiation Therapy in Treating Patients With Prostate Cancer | unknown | Phase 1 | 198 | Royal Marsden NHS Foundation TrustOTHER | 1 | Aug 26, 2013 | clinicaltrials |
| NCT01124682 | 3-Dimensional Conformal Radiation Therapy in Treating Patients With Bladder Cancer Who Have Undergone Transurethral Resection of the Bladder | unknown | Phase 1 | 60 | Institute of Cancer Research, United KingdomOTHER | 1 | Aug 26, 2013 | clinicaltrials |
| NCT00246012 | A Safety and Efficacy Study of Intetumumab, Alone and in Combination With Dacarbazine, in Participants With Stage 4 Melanoma | completed | Phase 1 / Phase 2 | 144 | Centocor, Inc.INDUSTRY | 3 | Aug 19, 2013 | clinicaltrials |
| NCT01460888 | Radiotherapy & Olaparib in COmbination for Carcinoma of the Oesophagus(ROCOCO) | unknown | Phase 1 | 36 | The Christie NHS Foundation TrustOTHER | 1 | Aug 19, 2013 | clinicaltrials |
| NCT01238185 | Aspirin Mouthwash in Treating Patients With Oral Leukoplakia | completed | Phase 1 | 40 | Institute of Head and Neck Studies and Education, United KingdomOTHER | 1 | Aug 12, 2013 | clinicaltrials |
| NCT00248521 | 17-Dimethylaminoethylamino-17-Demethoxygeldanamycin (17-DMAG) in Treating Patients With Metastatic Solid Tumors or Tumors That Cannot Be Removed By Surgery | unknown | Phase 1 | 35 | Institute of Cancer Research, United KingdomOTHER | 1 | Aug 2, 2013 | clinicaltrials |
| NCT01013818 | A Study of HGS1029 in Subjects With Relapsed or Refractory Lymphoid Malignancies | terminated | Phase 1 | 11 | Human Genome Sciences Inc.INDUSTRY | 2 | Aug 2, 2013 | clinicaltrials |
| NCT01297530 | Clinical Study to Evaluate the Maximum Tolerated Dose of BAY87-2243 in Patients With Advanced Malignancies | terminated | Phase 1 | 5 | BayerINDUSTRY | 3 | Jul 30, 2013 | clinicaltrials |
| NCT01476085 | Evaluating the Utility of the Apoptosis Imaging Biomarker 18F]ML10 in Patients With Non-Hodgkin's Lymphoma(NHL) | terminated | Phase 1 | 1 | GlaxoSmithKlineINDUSTRY | 1 | Jul 1, 2013 | clinicaltrials |
| NCT00003969 | Geldanamycin Analogue in Treating Patients With Advanced Cancer | completed | Phase 1 | — | Cancer Research UKOTHER | 1 | Jun 26, 2013 | clinicaltrials |
| NCT00006476 | Suramin in Treating Patients With Recurrent Bladder Cancer | completed | Phase 1 | 15 | Cancer Research UKOTHER | 1 | Jun 26, 2013 | clinicaltrials |
| NCT00513981 | High-Dose Methotrexate in Treating Young Patients With Solid Tumors | completed | Phase 1 | 36 | Children's Cancer and Leukaemia GroupOTHER | 2 | Jun 26, 2013 | clinicaltrials |
| NCT00081237 | OSI-7904L and Oxaliplatin in Treating Patients With Refractory or Recurrent Advanced Colorectal Cancer | completed | Phase 1 | 15 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 2 | Jun 12, 2013 | clinicaltrials |
| NCT00098982 | Bortezomib, Fluorouracil, Leucovorin, and Oxaliplatin in Treating Patients With Advanced or Metastatic Colorectal Cancer | completed | Phase 1 | 16 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 3 | Jun 12, 2013 | clinicaltrials |
| NCT00785122 | IMA910 Plus GM-CSF With Low-dose Cyclophosphamide Pre-treatment in Advanced Colorectal Carcinoma Patients Following a Successful 12 Week First-line Treatment With Oxaliplatin-based Chemotherapy (IMA910-101)(IMA910-101) | completed | Phase 1 / Phase 2 | 92 | Immatics Biotechnologies GmbHINDUSTRY | 9 | May 16, 2013 | clinicaltrials |
| NCT01118611 | Aurora B/C Kinase Inhibitor GSK1070916A in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 38 | Cancer Research UKOTHER | 1 | May 1, 2013 | clinicaltrials |
| NCT01664728 | An Expanded Access Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer Who Have Completed Clinical Study COU-AA-001 | completed | Phase 1 | 54 | Janssen Research & Development, LLCINDUSTRY | 1 | Apr 19, 2013 | clinicaltrials |
| NCT00600535 | A Pharmacokinetics Study to Assess Abiraterone Acetate Capsule and Tablet Formulations in Patients With Prostate Cancer | completed | Phase 1 | 31 | Cougar Biotechnology, Inc.INDUSTRY | 2 | Apr 17, 2013 | clinicaltrials |
| NCT00698243 | Study of Oral OSI-027 in Patients With Advanced Solid Tumors or Lymphoma | completed | Phase 1 | 128 | Astellas Pharma IncINDUSTRY | 3 | Apr 15, 2013 | clinicaltrials |
| NCT00314782 | Phase I Study of ZD4054 (Zibotentan) and Docetaxel in Patients With Metastatic HRPC | completed | Phase 1 | 44 | AstraZenecaINDUSTRY | 3 | Mar 12, 2013 | clinicaltrials |
| NCT00741377 | A Study to Assess BHQ880 in Combination With Zoledronic Acid in Relapsed or Refractory Myeloma Patients | completed | Phase 1 | 28 | Novartis PharmaceuticalsINDUSTRY | 2 | Feb 18, 2013 | clinicaltrials |
| NCT00551122 | Gemcitabine, Paclitaxel, Ifosfamide, and Cisplatin in Treating Patients With Progressive or Relapsed Metastatic Germ Cell Tumors(GemTIP) | unknown | Phase 1 / Phase 2 | 23 | University of SouthamptonOTHER | 1 | Jan 23, 2013 | clinicaltrials |
| NCT00097747 | Safety and Pharmacokinetics of Single Intravenous Doses of Peginesatide in Healthy Volunteers | completed | Phase 1 | 28 | AffymaxINDUSTRY | 1 | Dec 21, 2012 | clinicaltrials |
| NCT01337518 | A Phase 1a/1b Study to Evaluate the Safety of EZN-4176, in Adult Patients With Castration-Resistant Prostate Cancer | suspended | Phase 1 | 150 | Enzon Pharmaceuticals, Inc.INDUSTRY | 2 | Dec 18, 2012 | clinicaltrials |
| NCT00098969 | UMCC 2003-064 Resveratrol in Preventing Cancer in Healthy Participants(IRB 2004-535) | completed | Phase 1 | 40 | National Cancer Institute (NCI)NIH | 2 | Dec 17, 2012 | clinicaltrials |
| NCT01308762 | A Clinical Study, to Evaluate the Safety and Tolerability of Intradermal IMM-101 in Adult Melanoma Cancer Patients | completed | Phase 1 | 19 | Immodulon Therapeutics LtdINDUSTRY | 1 | Dec 6, 2012 | clinicaltrials |
| NCT00742495 | Pharmacokinetic Study of Forodesine in Children With Relapsed or Refractory T-cell or B-cell Precursor Acute Lymphoblastic Leukaemia or T-cell Non- Hodgkin's Lymphoma.(BCX1777-108) | terminated | Phase 1 / Phase 2 | 2 | Mundipharma Research LimitedINDUSTRY | 6 | Oct 24, 2012 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials